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Objecti ve: To evaluate the oral health status i.e., gingival 
conditi on, dental caries, oral mucosal lesions progression in a 
group of HIV positi ve children in relati on to CD4 count.
Method: A total of 234 HIV positi ve children in the age group 
of 2-15 years were included in the present study. Dental caries 
status was evaluated as per the criteria devised by WHO. 
Gingival conditi on index was used to assess and criteria given 
by Muhlemann was used for Papillary Bleeding scores. Plaque 
was assessed using the Sillness and Loe Index. The children 
were under acti ve anti retroviral therapy the CD4 count of each 
pati ent was available from the hospital records.
Results: Maximum dmft /defs, score was observed in individuals 
with CD4 count 200 - 500. Whereas highest mean DMFT/DMFS 
score was seen in children with CD4 count less than 200. The 
mean plaque, gingival and papillary bleeding score were highest 
in individuals with CD4 count less than 200 but the diﬀ erence 
was stati sti cally insignifi cant. Pseudomembranous candidiasis 
was the most observed oral lesion. Tongue was the most 
common site of occurrence of oral lesions in all groups.
Conclusion: The study confi rms that the oral health status in HIV 
positi ve children deteriorates with the decline in CD4 count. 
Objeti vo: Avaliar a condição de saúde bucal (condição gengival, 
cárie dentária, lesões na mucosa oral) em um grupo de crianças 
HIV positi vas em relação à contagem de CD4.
Método: Um total de 234 crianças HIV positi vas com idades 
entre 2 e 15 anos foram examinadas. A cárie dentária foi 
avaliada segundo os critérios da OMS. Os tecidos gengivais 
foram analisados sendo empregado o índice de sangramento 
gengival. Para a presença de biofi lme dental empregou-se o 
índice de Sillness e Loe. As crianças encontravam-se sob terapia 
anti viral e a contagem de CD4 de cada um dos pacientes foi 
obti da por meio dos prontuários hospitalares. 
Resultados: Os escores máximos ceo-d/ceo-s foram observados 
nas crianças cuja contagem de CD4 estava entre 200 - 500. 
Entretanto, as médias mais altas do cpo-d/cpo-s foram vistas 
nas crianças com contagem de CD4 menor de 200. As médias 
de placa, sangramento gengival foram mais elevados nos 
indivíduos com contagem de CD4 menor que 200, sem diferença 
estati sti camente signifi cante. Candidíase pseudomembranosa 
foi a lesão oral mais observada. A língua foi o local mais comum 
de ocorrência de lesões bucais em todos os grupos.
Conclusão: A condição de saúde bucal em crianças HIV positi vas 
deteriora-se com o declínio da contagem de células CD4.
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INTRODUCTION
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Profound immunosuppression caused by HIV/AIDS 
renders the host suscepti ble to a plethora of opportunisti c 
infecti ons1-4. Signifi cant but oft en ignored aspect of HIV/
AIDS is its oral manifestati ons. Oral health care is an 
important component of all round care for people with 
HIV infecti on.
The lack of healthy, functi oning denti ti on can 
adversely aﬀ ect the quality of life, complicate the 
management of medical conditi ons, and create or 
exacerbate nutriti onal and psychosocial problems5.
Oral lesions are a source of substanti al HIV associated 
morbidity.  In additi on certain oral lesions are markers for 
progressive immunologic dysfuncti on and HIV disease 
progression6-9.
Hence the present study was planned with the aim 
to ascertain the status of periodontal disease, dental 
caries and oral mucosal lesions in HIV infected children in 
relati on to CD4 count.
The study was carried out at HIV/AIDS Centre of 
King Edward Memorial Hospital and Seth G.S. Medical 
College, Parel, Mumbai as well as Ashraya, the Insti tute 
for desti tute children, Mumbai, India.  Before the start 
of the project, the Ethical Committ ee Clearance was 
obtained from Ethics Committ ee of Seth G.S. Medial 
College and KEM Hospital.
The concerned authoriti es, parents and caretakers 
were informed about the purpose of the study and an 
informed consent was obtained. 
The subjects considered were 234 confi rmed positi ve 
cases of HIV in the age group of 2 to 15 years under anti  
retroviral therapy (HAART). The history confi rmed that 
the children acquired the infecti on through verti cal 
transmission. Individuals were excluded if they had 
any physical or mental conditi on that would preclude 
cooperati on or performance of oral hygiene procedures.
The pati ents were seated comfortably on a dental 
chair and examined under adequate illuminati on. The 
oral examinati on included dental, soft  and hard ti ssue 
examinati on using mouth mirrors, graduated probes, 
disclosing soluti on (Erythrosine dye, Plak-See, ICPA labs 
India) and an HIV kit comprising of a disposable head cap, 
mouth mask, apron, eye glasses, gloves and shoe covers.
Oral examinati on started with the examinati on 
of teeth. Dental caries was recorded as per the WHO 
criteria10.
MATERIALS AND METHODS
Dental plaque was assessed as per the criteria 
described by Sillness and Loe11.  A disclosing agent was 
applied to the teeth and the level of plaque was scored 
as per the specifi ed criteria.
The gingival health was assessed as described by Loe 
and Silness12.  To describe the clinical severity of gingival 
infl ammati on buccal, lingual, mesial and distal surfaces 
of the specifi ed teeth were examined and scored. For 
further assessment papillary bleeding on probing was 
recorded using the Papillary Bleeding Index13.
Aft er assessing the  gingival health status a detailed 
examinati on for mucosal lesions was carried out starti ng 
with the perioral ti ssues, lips, labial mucosa, buccal 
mucosa, alveolar mucosa, gingiva, fl oor of mouth, tongue, 
hard palate and fi nally soft  palate. No radiographs were 
taken during the study. Demographic data included 
age and gender of the children. CD4 count and other 
relevant medical data (health history) was obtained from 
the hospital records. No dental or oral treatment was 
undertaken on any of the pati ents during the course of the 
study. However the treatment plan was discussed with 
the caretakers and an appointment was made for routi ne 
dental treatment.  All the individuals were examined by 
a single examiner, following universal infecti on control 
procedures, and the clinical fi ndings were recorded on a 
proforma by a trained assistant.
The data was tabulated and analyzed to obtain the 
descripti ve stati sti cs and frequency distributi on of the 
demographic data according to the clinical variables.  The 
data collected on periodontal disease, dental caries and 
oral mucosal lesions was tabulated and analyzed by Chi 
Square Test, One Way Annova Test and McNemar Bowker 
Test.
RESULTS
A total of 234 children, belonging to the age group 
2-15 were examined. At the ti me of oral examinati on, 
66 children had CD4 count less than 200, whereas 106 
children had CD4 count in the range of 200 to 500 and 62 
children had a count greater than 500. 
Mean deft  Score of 6.00, 7.15 and 5.26 was observed 
in individuals with CD4 count less than 200, 200 to 500 and 
more than 500 respecti vely (Table 1). Maximum mean 
deft  score was observed in individuals with CD4 count 
less than 200.  The diﬀ erence was stati sti cally signifi cant 
(F value = 2.9, p value = .05). The mean defs score of 
18.33, 21.33 and 13.08 was noted in individuals with 
CD4 count less than 200, 200 to 500 and more than 500 
respecti vely (Table 1).  Maximum defs score was observed 
in individuals with CD4 count 200 – 500, followed by 
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Table 1. Mean deft /defs scores according to CD4 count.
CD4 count Mean deft P Value Mean defs P Value
<=199 6.0179 18.3333
200-499 7.1548 0.05 21.3333 0.026
>=500 5.2600 13.0800
Total 6.3211 18.2766
individuals with CD4 count below 200 and more than 500 
respecti vely. The diﬀ erence is highly signifi cant (F value = 
3.7, p value = 0.026).  
The maximum mean DMFT of 4.34 was observed in 
individuals with CD4 count less than 200. The score was 
3.76 and 3.44 in individuals with CD4 count 200 – 500 and 
more than 500 respecti vely (Table 2).  The diﬀ erence of 
DMFT score in individuals with CD4 count less than 200 
and others was slightly insignifi cant (F value = 2.63, p 
value = 0.072). Similar results for DMFS were recorded 
(Table 2).
Table 2. Mean DMFT/DMFS scores  according  to CD4 count.
CD4 count Mean deft P Value Mean defs P Value
<=199 4.3436 10.6834
200-499 3.7692 0.072 8.4551 0.05
>=500 3.4490 9.3125
Total 4.0560 9.7905
On examining the oral mucosal lesions, it was 
observed that tongue was the most common site of 
involvement in individuals with CD4 count less than 200. 
Pseudomembranous candidiasis was the most common 
oral lesion observed (Table 3).
Mean plaque score of 1.22 was recorded in children 
with CD4 count less than 200, 1.23 in children with CD4 
count between 200 and 500 and 1.26 in children with 
CD4 count more than 500 (Table 4). This diﬀ erence 
was insignifi cant stati sti cally. Mean gingival score of 
1.22 in individuals with CD4 count less than 200, 1.20 
in individuals with CD4 count between 200 and 500 
Table 3. Oral mucosal lesions.
Oral Mucosal Lesions n %
Perioral Area/Lips 3 6.4
Perioral Area/Lips+Buccal Mucosa 0 0.0
Perioral Area/Lips+Buccal Mucosa +Palate 0 0.0
Perioral Area/Lips+Buccal Mucosa+Floor of the 
Mouth+Gingiva
0 0.0
Perioral Area/Lips+Buccal Mucosa+Vesti bule+ 
Palate
0 0.0
Perioral Area/Lips+Floor of the Mouth+ Gingiva 2 4.3
Perioral Area/Lips+Gingiva 1 2.1
Perioral Area/Lips+Alveolar Mucosa,Tongue 1 2.1
Perioral Area/Lips+Tongue 4 8.5
Palate 1 2.1
Oropharynx 8 17.0
Others 6 12.8
Buccal Mucosa 0 0.0
Buccal Mucosa +Palate 0 0.0
Buccal Mucosa+Gingiva 1 2.1
Buccal Mucosa+Gingiva+Tongue 0 0.0
Buccal Mucosa+Alveolar Mucosa,Tongue 0 0.0
Buccal Mucosa+Vesti bule 0 0.0
Vesti bule+Tongue 0 0.0
Labial Mucosa  2 4.3
Sublingual Mucosa 0 0.0
Gingiva+Tongue 0 0.0
Alveolar Mucosa 1 2.1
Alveolar Mucosa+Tongue 1 2.1
Vesti bule 1 2.1
Tongue 15 31.9
Total 47 100.0
Table 4. Depicti ng mean plaque score, mean gingival score and  mean papillary bleeding score 
according to CD4 count.
CD4 count Mean deft P Value Mean defs P Value Mean Papillary Bleeding 
Score
P Value
<=199 1.22168 1.22157 1.1874
200-499 1.23092 .525 1.20839 0.05 1.1748 .879
>=500 1.26193 1.19211 1.1629
Total 1.23049 1.21294 1.1796
and 1.19 in individuals with CD4 count more than 500 
was observed. The mean gingival score was highest in 
individuals with CD4 count less than 200 (Table 4) but the 
diﬀ erence was stati sti cally insignifi cant (F value = .487, p 
value = .615). Mean papillary bleeding score recordings 
were 1.18 in children with CD4 count less than 200, 1.17 
in children with CD4 count between 200 and 500 and 1.16 
in children with CD4 count more than 500 (Table 4). The 
maximum mean papillary bleeding score was observed 
in individuals with CD4 count less than 200. However, the 
diﬀ erence between groups was stati sti cally insignifi cant. 
(F value = .128, p value = .879).
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DISCUSSION
It has been reported that 40 to 50% of HIV infected 
people suﬀ er from oral or dental problems. Oral lesions 
are a source of substanti al HIV associated morbidity 
even in those who are on modern HIV therapy. In 
additi on certain oral lesions are markers for progressive 
immunologic dysfuncti on and HIV disease progression14-
16. It has been observed that oral lesions are the fi rst and 
foremost indicators of HIV/AIDS7.
Some common problems associated with HIV/AIDS 
are development of fever, blisters, Kaposi’s sarcoma, oral 
warts, canker soars, oral hairy leukoplakia, gingival and 
periodontal diseases, thrush, swelling in salivary glands, 
enlarged lymph nodes, dry mouth, viral oral lesions 
and herpes simplex lesions etc5,18,19. The side eﬀ ects of 
medicati ons commonly used may also aﬀ ect the oral 
health. Salivary fl ow may be diminished by anti cholinergics 
or adrenergic inhibitors resulti ng in xerostomia. Gingival 
hyperplasia may be caused by phenytoin. Oral candidiasis 
may be exacerbated by anti bioti cs. Didanosine (ddI) 
and zalcitabine (ddC) may cause painful oral ulcers. 
Other side eﬀ ects of medicati ons commonly used in the 
treatment of HIV, such as anaemia, thrombocytopenia, 
and neutropenia may be manifested in the oral cavity 
through bleeding or infecti on20-22. The sweetners used 
in pediatric syrups contribute to development of dental 
caries.
A number of studies have been reported in India 
pertaining to the general health status of HIV positi ve 
children but  no exclusive study has been carried out to 
ascertain the oral health status as an indicator of disease 
progression.
Available informati on suggests that HIV infected 
children have many of the oral manifestati ons observed 
in HIV infected adults, but disti nguishing features have 
been noted23. A vast majority of children with HIV 
infecti on present oral manifestati ons among the fi rst signs 
of illness24.  They observed that the oral lesions which 
appear in the infected children diﬀ er in prevalence from 
those seen in sero positi ve adults. Paroti d hypertrophy is 
present more exclusively in children whereas periodontal 
bacterial infecti ons and Kaposi’s sarcoma predominate 
in adult populati on. Prospecti ve studies are needed 
to determine the prevalence and natural history of 
oral lesions to examine the relati onships between 
immunologic and virologic markers of HIV disease status 
and the occurrence of oral manifestati ons, to evaluate 
changes in oral microbial fl ora of HIV-infected individuals 
over ti me, and to assess the causati ve nature of oral 
lesions comprehensively.  
The fi ndings of the present study are similar to 
those reported in other developed and developing 
countries and emphasize the need for educati on on 
the appropriate management and referral of pati ents 
presenti ng with oral manifestati ons of HIV infecti on25-29. 
In the present study, 234 HIV children att ending the ART 
Centre of infecti ous diseases were studied, 6.4% of HIV 
positi ve children showed an associati on with perioral 
lesions. The lesions most commonly occurred on tongue 
and  buccal mucosa. Candidiasis Linear gingival erythema 
and apthous mucosal stomati ti s were common. Children 
with CD4 count less than 200 cells/mm3 were more 
suscepti ble to develop these lesions. At the ti me of oral 
examinati on 66 pati ents had CD4 count less than 200 
whereas 106 children had CD4 count in the range of 200 
to 500. Caries occurrence rate was seen to be high and 
most of it was untreated.
deft /DMFT, defs/DMFS scores in the HIV positi ve 
children recorded in the current study were high possibly 
due to high intake of carbohydrate, sweetened medicines 
as well as xerostomia. It is vital to ensure that whenever 
possible sugar free medicati ons are prescribed to 
children and also they must receive appropriate advice 
and necessary support to access dental care services.
Oral manifestati ons are common in children 
infected with HIV and are associated with serious 
immunosuppression and AIDS. They are indicators of 
the infecti on with a predicti ve value of its progression. 
In the present study oral candidiasis was present in 
20.6% of the cases. Pseudomembranous candidiasis 
was the most common type.
The frequency of gingiviti s was high, this could 
be att ributed to dryness of mouth. Ulcerati on and 
painful oral lesions were frequently observed which 
interfered with the performance of daily oral hygiene 
procedures. The average CD4 percentage was low for 
children with gingiviti s and most of them had serious 
immunosuppression.  More lesions were present in the 
oral cavity in immunologically compromised pati ents. 
A low value for CD4 characterizing the presence of 
immunosuppression, is a predisposing factor for the 
development of opportunisti c infecti ons. The study also 
verifi es a relati on between increased immunosuppression 
and the presence of candidiasis. Even though the children 
in the present study were on anti retroviral therapy it was 
seen that some of them exhibited candidiasis. A possible 
explanati on for this could be their low CD4 count and 
their immunocompromized status. 
The introducti on of HAART is associated with a 
signifi cant decrease in the prevalence of opportunisti c 
diseases including oral mucosal lesions. HAART is also 
associated with a signifi cant decrease in the prevalence 
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of oral candidiasis and oral hairy leukoplakia coupled 
with an improved CD4 count
30-32.  
Seemingly in contradicti on with these fi ndings, an 
increased prevalence of oral warts has been noted by 
some investi gators despite a marked improvement in CD4 
count. This observati on may not refl ect true increased 
prevalence in the populati on. However, because of 
the link between human papilloma virus and cancer, it 
suggests that, with increased life expectancy of HIV-
infected pati ents, oral cancer may become a clinically 
signifi cant long-term complicati on.
Results of studies conducted by other authors33 
confi rmed a decline in prevalence of oral mucosal lesions 
in industrialized countries with the introducti on of bett er 
anti  retroviral therapies. However, an increase in salivary 
gland disease, xerostomia and oral warts was observed. 
Taken together, the occurrence rate of Oral mucosal 
lesions in the post HAART era indicates that Oral mucosal 
lesions are less frequent, but new and poorly understood 
paradigms are emerging34.
The authors emphasize a need for further longitudinal 
studies with frequent oral examinati ons of children to 
establish a relati on between HIV and oral health status 
of HIV positi ve children, parti cularly in relati on to the 
progression of the disease as esti mated by the depleti on 
of CD4 counts in blood.
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